Musculoskeletal Diseases or ConditionsNCT07700017
Short- and Medium-term Outcomes of the 3- Versus 4-week PV RehaJET® Rehabilitation Programme
An observational study of Musculoskeletal Diseases or Conditions, run by Pensionsversicherungsanstalt at 1 site in Austria.
Trial summary
The objective of this observational study is to evaluate and compare the outcomes of two different durations of a recently established work-specific rehabilitation programme in Austria. The programme focuses on exercises tailored to patients' individual vocational needs. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Musculoskeletal Diseases or Conditions
- What is being tested?
- Multimodal rehabilitation with additional work specific training
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 499 participants
- Where
- 1 siteAustria
- Study dates
- 7 Jul 2026to 7 Jul 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients with specific work-related rehabilitation needs
Who may be able to join
- The study participants are patients undergoing the REHAJET programme
- Presence of a disease in the area of the musculoskeletal system
- Sufficient motivation to maintain professional participation
Who cannot join
- No completion of all work-specific rehabilitation modules
- Acute or decompensated disease states with severe functional limitations (i.e. not able to continue with the rehabilitation programme)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Kurz- Und Mittelfristige Outcomes Des 3- Versus 4-wöchigen PV RehaJET® Erstheilverfahrens
The objective of this observational study is to evaluate and compare the outcomes of two different durations of a recently established work-specific rehabilitation programme in Austria. The programme focuses on exercises tailored to patients' individual vocational needs. Two patient groups are observed: one group completes a three-week work-specific rehabilitation programme, while the other group completes a four-week work-specific rehabilitation programme, allowing a direct comparison of their outcomes.
Read the detailed description
Secondary Data Analysis
- Conditions
- Musculoskeletal Diseases or Conditions
- Being tested
- Multimodal rehabilitation with additional work specific training
- Medical subject headings
- Musculoskeletal Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Multimodal rehabilitation with additional work specific trainingBehavioural
Also called RehaJET
The rehabilitation is based on the biopsychosocial ICF model of the WHO. Taking into account the physical and psychological condition of the patients, an individual therapy plan is created that is tailored to the needs of the patients.
| Study group | Role | What they receive |
|---|---|---|
| 3-week work-specific rehabilitation | Patients participate in a 3-week work-specific rehabilitation programme with exercises tailored to their individual vocational and work-related needs. Receives: Behavioral: Multimodal rehabilitation with additional work specific training | |
| 4-week work-specific rehabilitation | Patients participate in a 4-week work-specific rehabilitation programme with exercises tailored to their individual vocational and work-related needs. Receives: Behavioral: Multimodal rehabilitation with additional work specific training |
What is being measured
The primary outcome is the main question the study is designed to answer.
IMBA - Profile comparison
IMBA is a profile comparison method for prevention and rehabilitation. Job requirements and human capabilities are described by standardised, defined characteristics and compared directly with each other. The respective profile sheets consist, among other things, of 70 function-, activity- and context-related main characteristics in which the extent of excessive demands for each characteristic is documented on a scale of 0 - 6 (Min. = 0, Max = 420). Lower values indicate less excessive demands.
Measured: 3 or 4 weeks of inpatient rehabilitation
Employment history
The existence of gainful employment subject to social insurance contributions in a specific period allows conclusions to be drawn about the employment history of the rehabilitants.
Measured: 6 months after finishing rehabilitation
Secondary outcomes (3)
Work ability index (WAI)
The Work Ability Index (WAI) is an instrument for assessing work ability. (Min. = 7, Max = 49). Lower values indicate less subjective work ability.
Measured: 3 or 4 weeks of inpatient rehabilitation
Patient Health Questionnaire-4 (PHQ-4)
The Patient Health Questionnaire-4 (PHQ-4) operationalizes core criteria for anxiety and depression on a 4 point likert scale (Min. = 0, Max = 4). Lower values indicate less impairments.
Measured: 3 or 4 weeks of inpatient rehabilitation
European Quality of Life 5 Dimensions 5 Level (EQ-5D-5L)
The EQ-5D-5L is a general instrument for measuring patient-reported outcomes (PROs), which can be used to assess the quality of life of patients on different dimensions (mobility, self-care, usual activities, pain/discomfort) on a 5-level scale (Min. = 0, Max. = 5). Lower values indicate less impairments in the respective dimensions. Moreover, the EQ-5D-5L assesses the patient's self-rated health on a 100 point visual analog scale (Min. = 0, Max. = 100). Lower values indicate less positive ratings of health.
Measured: 3 or 4 weeks of inpatient rehabilitation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jul 2026
- Study start7 Jul 2026
- Primary completion7 Jul 2026
- Study completion7 Jul 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Musculoskeletal Diseases or ConditionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 499 participants (actual)
Sponsor and investigators
- Lead sponsor
- Pensionsversicherungsanstalt
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Doreen Stöhr, Mag., Study chair, Pensionsversicherungsanstalt
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07700017
- Sponsor's protocol ID
- 0088 PVRehaJET EHV Vergleich
- Status last verified
- Jul 2026
- First submitted
- 7 Jul 2026
- Last updated
- 13 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Kurz- Und Mittelfristige Outcomes Des 3- Versus 4-wöchigen PV RehaJET® Erstheilverfahrens
- ClinicalTrials.gov ID
- NCT07700017
- Acronym / sponsor ID
- 0088 PVRehaJET EHV Vergleich
- Conditions
- Musculoskeletal Diseases or Conditions
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 499 participants (actual)
- Lead sponsor
- PensionsversicherungsanstaltUniversity, hospital or other
- Study start
- 7 Jul 2026 (actual)
- Primary completion
- 7 Jul 2026 (actual)
- Study completion
- 7 Jul 2026 (actual)
- First posted
- 13 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this observational study is to evaluate and compare the outcomes of two different durations of a recently established work-specific rehabilitation programme in Austria. The programme focuses on exercises tailored to patients' individual vocational needs. Two patient groups are observed: one group completes a three-week work-specific rehabilitation programme, while the other group completes a four-week work-specific rehabilitation programme, allowing a direct comparison of their outcomes.
Detailed description
Secondary Data Analysis
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 3-week work-specific rehabilitation | – | Behavioral: Multimodal rehabilitation with additional work specific trainingPatients participate in a 3-week work-specific rehabilitation programme with exercises tailored to their individual vocational and work-related needs. |
| 4-week work-specific rehabilitation | – | Behavioral: Multimodal rehabilitation with additional work specific trainingPatients participate in a 4-week work-specific rehabilitation programme with exercises tailored to their individual vocational and work-related needs. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients with specific work-related rehabilitation needs
Key inclusion criteria (3 listed)
- The study participants are patients undergoing the REHAJET programme
- Presence of a disease in the area of the musculoskeletal system
- Sufficient motivation to maintain professional participation
Key exclusion criteria (2 listed)
- No completion of all work-specific rehabilitation modules
- Acute or decompensated disease states with severe functional limitations (i.e. not able to continue with the rehabilitation programme)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Multimodal rehabilitation with additional work specific trainingAlso: RehaJETThe rehabilitation is based on the biopsychosocial ICF model of the WHO. Taking into account the physical and psychological condition of the patients, an individual therapy plan is created that is tailored to the needs of the patients. | Behavioural | 3-week work-specific rehabilitation, 4-week work-specific rehabilitation |
Primary outcome
IMBA - Profile comparison
Time frame: 3 or 4 weeks of inpatient rehabilitation
IMBA is a profile comparison method for prevention and rehabilitation. Job requirements and human capabilities are described by standardised, defined characteristics and compared directly with each other. The respective profile sheets consist, among other things, of 70 function-, activity- and context-related main characteristics in which the extent of excessive demands for each characteristic is documented on a scale of 0 - 6 (Min. = 0, Max = 420). Lower values indicate less excessive demands.
Employment history
Time frame: 6 months after finishing rehabilitation
The existence of gainful employment subject to social insurance contributions in a specific period allows conclusions to be drawn about the employment history of the rehabilitants.
3 secondary outcomes
Work ability index (WAI)
Time frame: 3 or 4 weeks of inpatient rehabilitation
Patient Health Questionnaire-4 (PHQ-4)
Time frame: 3 or 4 weeks of inpatient rehabilitation
European Quality of Life 5 Dimensions 5 Level (EQ-5D-5L)
Time frame: 3 or 4 weeks of inpatient rehabilitation
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jul 2026.
Related trials for Musculoskeletal Diseases or Conditions
Recruiting
ITPB 1 vs 3 in VATS
Musculoskeletal Diseases or Conditions
Recruiting
Minimum Effective Local Anesthetic Volume for Ultrasound Guided Superior Trunk Block
Musculoskeletal Diseases or Conditions
RecruitingPhase 4
Prospective RCT Lidocaine & Levobupivacaine on Block Dynamics After Subparaneural Popliteal Sciatic Nerve Block
Musculoskeletal Diseases or Conditions
Recruiting
Sensorimotor Block Dynamics and Hemidiaphragmatic Palsy: Selective Trunk Block vs Supraclavicular Brachial Plexus Block
Musculoskeletal Diseases or Conditions
RecruitingPhase 3
A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
Obesity, Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Doreen Stöhr, Mag. study chair
Pensionsversicherungsanstalt
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Musculoskeletal Diseases or Conditions, run by Pensionsversicherungsanstalt at 1 site in Austria.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
IMBA - Profile comparison (time frame: 3 or 4 weeks of inpatient rehabilitation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2026.